David Allen Jones Jr. - 03 Jan 2022 Form 4 Insider Report for HUMANA INC (HUM)

Role: Director
Signature: David A. Jones, Jr.
Issuer symbol: HUM
Transactions as of: 03 Jan 2022
Net transactions value: $0
Form type: 4
Filing time: 05 Jan 2022, 12:03:14 UTC
Previous filing: 19 Nov 2021
Next filing: 23 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HUM	Humana Common	Award	$0	+412		$0.000000	412	03 Jan 2022	Direct	F5
holding	HUM	Humana Common						800	03 Jan 2022	See Footnote	F1
holding	HUM	Humana Common						68,328	03 Jan 2022	See Footnote	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	HUM	Restricted Stock Units						5,892	03 Jan 2022	Humana Common	5,892		Direct	F2
holding	HUM	Restricted Stock Units						95	03 Jan 2022	Humana Common	95		Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held in two trusts for the benefit of reporting person's son/daughter, respectively, in each case where the reporting person is the sole trustee.
F2	Annual Director's fee payable in stock units which have been deferred at the election of the reporting person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
F3	Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).
F4	Shares held by a revocable trust account (Dec 2009), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock. Includes 403 shares that vested on 12/31/21 and transferred to trust on 1/3/22.
F5	Includes 412 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/22.